UK High Court judge unconvinced by Pfizer that uniQure’s patent is invalid | Companies in dispute over patents covering ...

Former head of life sciences at Gowling, joins Cooley’s London office as a partner | Brings expertise in cross-border ...

A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 ...

Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen ...

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

Keo McKenzie re-joins firm’s Washington, DC office, bringing over a decade of experience in AI, healthcare, and technology law. Already registered?

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

In-house pharma and biotech lawyers are taking on broader roles, from handling regulatory issues to corporate strategy—and outside counsel can help, finds Marisa Woutersen.

10x Genomics senior director of IP and litigation shares her team's tasks, how she’s handling UPC litigation, and why sometimes she wants a ‘gut answer’ from externals, finds Marisa Woutersen.